CMS Nederland Consumer Products

Consumer Products

Netherlands

As a player in the consumer products sector, you face a myriad of challenges such as strong competition, globalisation and digitalisation, legislative changes, environmental and health concerns, volatile commodity prices, supply chain management, consumer and media pressure, growing retailer buyer power, the rise of online selling and counterfeiting. All place new demands on your management and business strategy but also drive the need for legal advice. Our pan-European team is structured around the key sectors of consumer products including cosmetics, clothing, electronics, health & beauty, food & drink, retail, household equipment and manufacturing. Whether you are a supplier, investor, regulator or other stakeholder, we have consumer products experts to help, whatever your situation.

In order to give you the targeted legal advice your business needs, our teams have experts from every legal area affecting your sector. This means we can guide you on all legal and regulatory aspects - from the financing and acquisition of companies, through to antitrust and unfair competition law, media management, nutritional and health claims, advertising and marketing, strategies for the protection of intellectual property rights, data protection, outsourcing, distribution agreements, real estate transactions, product recalls and much more. Our experts will keep you abreast of the latest sector insight and developments, giving you a commercial, as well as a legal, edge.

Read more Read less

Mark Ziekman leads CMS’ department, which is strong in IP, advertising and corporate matters. Senior associate Herman van Aerts advised DIDIX on its sale of Tastecard and The Gourmet Society to Bridgepoint Development Capital. Ellen Gielen assisted Worlée with various food law matters. IP experts Marcoline van der Dussen, Willem Hoorneman and Rogier de Vrey are recommended.

Legal 500, 2017

CMS’ multidisciplinary practice is ‘available 24/7 and very reliable’.

The Legal 500, 2017

Choose area

    Automotive

    CMS has automotive specialists with a wide experience in the automotive industry. We know what is going on in the sector and can give you personalized advice and assistance.

    Read more

    Product Liability

    Sooner or later it happens to every businessman: a party you are dealing with fails to fulfill his obligations. Even if you manage to get that party to do so in the end, you will still be confronted with costs which will not be compensated for.

    Read more
    December 2017
    Mis­lead­ing rep­res­ent­a­tions of new "de­sign­er food"
    April 2018
    CMS guide to Elec­tric Vehicles
    13/11/2017
    Over­view of re­tail lease agree­ments

    Feed

    Show only
    Małgorzata Urbańska
    December 2017
    Mis­lead­ing rep­res­ent­a­tions of new "de­sign­er food"
    17/04/2018
    NGOs can ask the Com­mis­sion to re­view its de­cision on ge­net­ic­ally...
    The Gen­er­al Court de­cided in its de­cision of 14 March 2018 that non-gov­ern­ment­al or­gan­iz­a­tions (“NGOs”) can ask the Com­mis­sion to re­view its de­cision on au­thor­iz­ing the pla­cing on the mar­ket of ge­net­ic­ally mod­i­fied food and feed.
    13/11/2017
    Over­view of re­tail lease agree­ments
    16/04/2018
    Ger­man court rules no lux­ury goods in food re­tail out­lets
    On 6 April 2018, the Düs­sel­dorf High­er Re­gion­al Court ruled that the food re­tail­er real, whose par­ent com­pany is Ger­many’s Metro AG, may not sell lux­ury cos­met­ics made by Japa-nese man­u­fac­turer Kanebo in its food re­tail stores, and that the man­u­fac­turer can.
    02/02/2018
    IBM Wat­son at work
    There may be much hype around ar­ti­fi­cial in­tel­li­gence but IBM has been demon­strat­ing the busi­ness po­ten­tial of ma­chine learn­ing through its Wat­son ana­lyt­ics plat­form since 2011. Wat­son came about after one of IBM’s re­search teams were at the pub watch­ing.
    25/01/2018
    European Com­mis­sion as­sesses ad­equacy of Gen­er­al Food Law in food...
    In an eval­u­ation of the EU le­gis­lat­ive frame­work for the 2002 Gen­er­al Food Law Reg­u­la­tion (GFLR), the European Com­mis­sion has found that this frame­work ap­pears to ad­dress most cur­rent trends, such as growth, com­pet­it­ive­ness and in­creased glob­al­isa­tion, but.
    28/03/2017
    On the road to autonom­ous vehicles
    Con­nec­ted and autonom­ous vehicle (“CAV”) tech­no­lo­gies are set to have a pro­found so­cial and eco­nom­ic im­pact world­wide and con­tin­ue to ac­cu­mu­late a great weight of ex­pect­a­tion. Ad­voc­ates ar­gue that CAV tech­no­lo­gies will im­prove road safety, ease con­ges­tion and.
    06/03/2017
    PIP-case: ECJ cla­ri­fies scope of no­ti­fied body’s re­spons­ib­il­it­ies...
    In the PIP-case, a French man­u­fac­turer sup­plied thou­sands of wo­men with (al­legedly) de­fect­ive breast im­plants. Amongst oth­ers, pa­tients in Ger­many star­ted lit­ig­a­tion against the no­ti­fied body in ques­tion - TÜV Rhein­land (“Tuv”).
    09/12/2016
    Are we wit­ness­ing the rise of su­per level eco­nom­ic en­vir­on­ment risks?
    In a few years’ time we may look back and say that it was in 2015/2016 when leg­al pro­ceed­ings and re­cent policy changes com­bined to pro­duce mani­fest ser­i­ous trans­fron­ti­er and trans-sec­tor com­mer­cial and eco­nom­ic en­vir­on­ment risk.
    05/12/2016
    ABS Reg­u­la­tion - Draft Bi­otech Sec­tor Stake­hold­er Guid­ance
    Views are be­ing sought from in­ter­ested stake­hold­ers on European guid­ance for the bi­o­tech­no­logy sec­tor con­cern­ing the EU’s ac­cess to ge­net­ic re­sources and shar­ing of be­ne­fits from util­isa­tion le­gis­la­tion – namely the ABS Reg­u­la­tion.
    28/10/2016
    European Com­mis­sion pub­lishes Cor­por­ate Tax Re­form Pack­age, re­launch­ing...
    As part of a Cor­por­ate Tax Re­form Pack­age, the EC has pub­lished four pro­pos­als for Coun­cil Dir­ect­ives. 1. Pro­pos­als to re­launch the Com­mon Con­sol­id­ated Cor­por­ate Tax Base First, the European Com­mis­sion (“EC”) has an­nounced that it is re­launch­ing its pro­pos­al.
    05/07/2016
    Leg­al de­vel­op­ments in product li­ab­il­ity: With re­strict­ive le­gis­la­tion...
    The med­ic­al in­dustry is un­der in­creas­ing leg­al pres­sure these days ow­ing mainly to a con­sumer-friendly risk en­vir­on­ment. This is evid­ent from re­strict­ive le­gis­la­tion and re­cent land­mark cases, such as the PIP case, con­cern­ing a French com­pany that sup­plied.